Health-care companies fell as traders rotated into cyclical sectors such as energy and materials.
The health-care sector has been among the stock market leaders in the last 12 months, as the global pandemic has boosted demand for all manner of medical goods and services.
Dutch Medical-device maker Royal Philips expanded the reach of its already huge recall of breathing-aid machines known as C-PAPs and BiPAPS, and warned supply-chain strains would hit fourth-quarter sales, weighing on shares.
Abbott Laboratories received commercial approval from the U.S. Food and Drug Administration for its new heart mapping platform.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
01-12-22 1631ET
